Transferrin (Tf) and apolipoprotein CIII (apoCIII) are biomarkers of N- and O-glycosylation disorders, respectively, and an abnormality in the glycans of these glycoproteins supports the diagnosis of CDG. The gene discussed is APOC3; the disease is congenital disorder of glycosylation.